Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06UYI
|
||||
| Former ID |
DCL000037
|
||||
| Drug Name |
AM103
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cardiovascular disorder [ICD10:I00-I99] | Discontinued in Phase 2 | [1] | ||
| Company |
Amira Pharma.
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H20N4O3
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Arachidonate 5-lipoxygenaseactivating protein | Target Info | Inhibitor | [2] | |
| NetPath Pathway | IL4 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| Leptin Signaling Pathway | |||||
| PANTHER Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | ||||
| WikiPathways | Nuclear Receptors Meta-Pathway | ||||
| Arachidonic acid metabolism | |||||
| Eicosanoid Synthesis | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026047) | ||||
| REF 2 | AM103 Experimental Treatment for Respiratory Diseases. Amira Pharmaceuticals/GSK. 2009. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.